American Portfolios Advisors Syndax Pharmaceuticals Inc Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, American Portfolios Advisors holds 400 shares of SNDX stock, worth $5,428. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400Holding current value
$5,428% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SNDX
# of Institutions
233Shares Held
90.6MCall Options Held
1.39MPut Options Held
543K-
Kynam Capital Management, LP Princeton, NJ8.52MShares$116 Million7.14% of portfolio
-
Black Rock Inc. New York, NY7.91MShares$107 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.31MShares$72.1 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.87MShares$66.1 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY3.92MShares$53.2 Million0.01% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $768M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...